Our study demonstrates that LAL deficiency in MSCs impairs their stimulation of tumor growth and metastasis by restricting MSC proliferation, reducing synthesis and secretion of tumor-promoting cytokines/chemokines, inducing CD8+ T lymphocytes and decreasing accumulation of MDSCs, and impairing differentiation towards TAFs. The gene discussed is CD8A; the disease is neoplasm.